Kyverna Therapeutics, Inc. (KYTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 241.73M | 282.95M | 174.93M | 214.33M | 247.65M | 290.6M | 325.37M | 348.82M | 375.49M | 60.66M | 79.41M | 375.49M |
| Cash & Short-Term Investments | 236.45M | 279.25M | 171.14M | 211.68M | 242.65M | 285.98M | 321.59M | 346.24M | 369.79M | 57.54M | 77.27M | 369.79M |
| Cash Only | 32.19M | 124.09M | 34.16M | 53.44M | 56.87M | 96.62M | 104.66M | 131.62M | 224.29M | 34.65M | 22.97M | 224.29M |
| Short-Term Investments | 204.25M | 155.16M | 136.97M | 158.24M | 185.78M | 189.36M | 216.92M | 214.62M | 145.51M | 22.9M | 54.31M | 145.51M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.28M | 3.7M | 3.79M | 2.65M | 5M | 4.62M | 3.79M | 2.59M | 5.69M | 3.12M | 0 | 0 |
| Total Non-Current Assets | 15.3M | 10.87M | 12.23M | 12.18M | 13M | 15.92M | 13.82M | 14.29M | 14.5M | 14.53M | 13.08M | 14.5M |
| Property, Plant & Equipment | 9.73M | 5.42M | 6.32M | 7.58M | 8.8M | 10.66M | 11.38M | 12.51M | 12.75M | 10.61M | 11.07M | 12.75M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 551K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.57M | 5.45M | 5.36M | 4.6M | 4.2M | 5.26M | 2.44M | 1.79M | 1.74M | 3.92M | 2M | 1.74M |
| Total Assets | 257.02M | 293.83M | 187.16M | 226.51M | 260.65M | 304.64M | 339.2M | 363.12M | 389.98M | 75.19M | 92.49M | 389.98M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -1.39% | -3.55% | -44.82% | -37.62% | -33.16% | 305.14% | 266.75% | -6.89% | - | - | - | - |
| Total Current Liabilities | 29.67M | 36.49M | 33.87M | 39.79M | 33.29M | 33.76M | 30.98M | 23.48M | 21.86M | 19.86M | 16.87M | 21.86M |
| Accounts Payable | 11.6M | 5.31M | 3.02M | 9.92M | 8.47M | 4.62M | 9.93M | 4.86M | 7.45M | 4.36M | 3.02M | 7.45M |
| Days Payables Outstanding | 2.17K | - | - | 1.62K | 1.18K | 1.19K | 23.31 | - | 23.91K | 19.78 | - | - |
| Short-Term Debt | 1.99M | 3.97M | 3.69M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 16.09M | 27.21M | 20.21M | 4.97M | 3.08M | 4.88M | 0 | 2.72M | 1.36M | 9.77M | 2.95M | 0 |
| Current Ratio | 8.15x | 7.75x | 5.16x | 5.39x | 7.44x | 8.61x | 10.50x | 14.86x | 17.17x | 3.05x | 4.71x | 17.17x |
| Quick Ratio | 8.15x | 7.75x | 5.16x | 5.39x | 7.44x | 8.61x | 10.50x | 14.86x | 17.17x | 3.05x | 4.71x | 17.17x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 31.77M | 25.06M | 1.34M | 2.34M | 3.35M | 4.3M | 5.5M | 6.13M | 7.13M | 6.16M | 6.84M | 7.13M |
| Long-Term Debt | 6.96M | 24.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 320K | 1.34M | 2.34M | 3.35M | 4.3M | 5.21M | 6.13M | 7.13M | 6.16M | 6.84M | 7.13M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 24.81M | 0 | 0 | 0 | 0 | 0 | 296K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 61.44M | 61.55M | 35.21M | 42.13M | 36.65M | 38.06M | 36.49M | 29.61M | 28.99M | 26.02M | 23.72M | 28.99M |
| Total Debt | 8.94M | 29.03M | 5.02M | 5.92M | 6.94M | 8.24M | 9.14M | 10M | 10.85M | 9.08M | 9.64M | 10.85M |
| Net Debt | -23.25M | -95.06M | -29.14M | -47.52M | -49.93M | -88.38M | -95.53M | -121.62M | -213.44M | -25.57M | -13.33M | -213.44M |
| Debt / Equity | 0.05x | 0.12x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.18x | 0.14x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -62.02x | -84.14x | -5254.29x | -3004.79x | -1784.40x | -1387.48x | -1158.44x | -737.54x | -0.64x | -454.83x | -308.30x | -283.59x |
| Total Equity | 195.58M | 232.28M | 151.95M | 184.38M | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M | 49.18M | 68.77M | 360.99M |
| Equity Growth % | -12.69% | -12.87% | -49.8% | -44.72% | -37.95% | 442.1% | 340.19% | -7.61% | - | - | - | - |
| Book Value per Share | 3.24 | 4.93 | 3.50 | 4.27 | 5.18 | 6.17 | 7.01 | 7.73 | 15.20 | 1.14 | 1.59 | 8.37 |
| Total Shareholders' Equity | 195.58M | 232.28M | 151.95M | 184.38M | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M | 49.18M | 68.77M | 360.99M |
| Common Stock | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -464.56M | -424.83M | -387.02M | -350.24M | -308.15M | -263.52M | -226.03M | -191.54M | -162.74M | -136.04M | -115.38M | -162.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -96K | 97K | 29K | -20K | -1K | 105K | 153K | -37K | -1K | 4K | 5K | -1K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |